Opendata, web and dolomites

EpiShuttle 2.0 SIGNED

EpiShuttle: Isolation and Transportation of Infectious Disease Patients

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EpiShuttle 2.0 project word cloud

Explore the words cloud of the EpiShuttle 2.0 project. It provides you a very rough idea of what is the project "EpiShuttle 2.0" about.

demonstrated    mers    zika    travelling    thousand    disinfection    size    position    reusable    world    usa    market       least    opportunity    madagascar    doctors    global    contagious    solution    representing    faced    engineering    tuberculosis    capital    patients    leap    re    transport    events    congo    specialized    12    risks    77    larger    drc    million    professionals    health    worldwide    company    lives    patterns    epidemic    complete    china    plague    people    sars    emergency    expand    polycarbonate    combining    11    globally    risk    modern    investment    security    isolate    care    cdc    west    economic    siu    treatment    group    labour    hard    recommends    patient    claimed    plus    launched    pulmonary    team    workflow    bill    2015    wants    standard    person    catastrophe    infectious    epishuttle    gas    isolation    positive    clearance    society    units    epiguard    virus    medical    2014    disease    eur    gold    asia    handle    first    diseases    founded    sius    outside    brazil    class    regulatory    partnering    compromising    manner    outbreaks    ebola    resistant    africa    infected    protection   

Project "EpiShuttle 2.0" data sheet

The following table provides information about the project.

Coordinator
EPIGUARD AS 

Organization address
address: TORSNESVEIEN 210
city: GAMLE FREDRIKSTAD
postcode: 1634
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Norway [NO]
 Total cost 3˙565˙000 €
 EC max contribution 2˙495˙500 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2021-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EPIGUARD AS NO (GAMLE FREDRIKSTAD) coordinator 2˙495˙500.00

Map

 Project objective

The Problem: An increasing number of outbreaks with infectious diseases are seen globally. Ebola has claimed at least 77 lives in DRC (Congo) so far this year and over 11 thousand people West Africa in 2014. Other recent outbreaks are the SARS-epidemic, the MERS-cases in Asia, multi-resistant tuberculosis and the pulmonary Plague epidemic in Madagascar, Zika virus in Brazil, etc. Each of these events demonstrated the large health, economic and security risks associated with infectious disease outbreaks. The travelling patterns of our modern society increases the risk of a global “catastrophe”. To handle outbreaks, the CDC highly recommends the use of specialized isolation units (SIU) to isolate and transport the infected patients. The Solution: EpiGuard was founded in 2015 by a group of medical doctors that faced the challenge of managing Ebola patients on the field. After 3 years and ~5 million EUR of capital and labour investment, the company has recently launched into EU market the EpiShuttle solution – the world-first hard-top (polycarbonate), reusable SIU, representing a leap forward against the state of the art. The EpiShuttle is a one-person SIU, providing complete protection from contagious diseases, without compromising advanced treatment and care to the patient. The Opportunity: Partnering with a world-class design and engineering team, EpiGuard wants to position EpiShuttle as the gold standard for SIUs in the emergency workflow. EpiShuttle targets a 12 Bill. EUR market opportunity worldwide. Although the response from medical professionals has been positive, to fully exploit the market potential, there is a need for combining modern gas disinfection technology with EpiShuttle to allow re-use in a cost effective manner. Further, to expand the market outside Europe, regulatory clearance in USA and China plus a larger size unit for the USA market are needed.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EPISHUTTLE 2.0" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EPISHUTTLE 2.0" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

Primavera (2018)

Primavera: immunobiotics for treating early stage Age-related Macular Degeneration (AMD)

Read More  

Click and Spray (2020)

A SIMPLER, CHEAPER AND EASIER TO RECYCLE AEROSOL CONTAINER

Read More